3B's Research Group, Research Institute on Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, University of Minho, Guimarães, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga, Guimarães, Portugal.
Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Biomater Adv. 2022 Mar;134:112575. doi: 10.1016/j.msec.2021.112575. Epub 2021 Dec 3.
The application of nanoparticles in magnetic resonance imaging (MRI) has been greatly increasing, due to their advantageous properties such as nanoscale dimension and tuneability. In this context, manganese (Mn)-based nanoparticles have been greatly investigated, due to their valuable use as a contrast agent, improving signal intensity and specificity in MRI (manganese-enhanced MRI, MEMRI). Additionally, Mn can act as scavengers of reactive oxygen species (ROS), commonly present in the inflammatory processes of neurodegenerative diseases. The aim of the present study was to develop nanoreactors, which can be used as contrast-agent in MEMRI. Several blends of methacrylated gellan gum (GG-MA) and hyaluronic acid (HA) were embedded with different types of manganese dioxide (MnO) nanoparticles and further physico-chemically characterized. Dynamic light scattering, scanning electron microscopy, water uptake and degradation studies were performed. In vitro cytotoxicity of the different formulations was also evaluated using an immortalized rat fibroblast cell line L929, up to 72 h of culturing. Synthesized nanoparticles were obtained with an average size of 70 nm and round-shaped morphology. The stability of the different formulations of hydrogels was not affected by nanoparticles' concentration or HA ratio. The presence of synthesized MnO2 (MnO2_S) nanoparticles reduced hydrogels' cytocompatibility, whereas the commercially available type 1 (MnO2_C1) nanoparticles were less toxic to cells. Additionally, cell proliferation and viability were enhanced when a lower content of HA was present. Higher concentrations (75 and 100 ng/mL) of MnO2_S and MnO2_C1 nanoparticles did not negatively affected cell viability, whereas the opposite effect was observed for the commercial type 2 (MnO2_C2) nanoparticles. Further studies are required to evaluate the potential application of the most promising nanoreactors' formulations for combined application in MEMRI and as ROS scavengers.
纳米粒子在磁共振成像(MRI)中的应用正在大幅增加,这得益于其纳米级尺寸和可调谐性等优势特性。在此背景下,锰(Mn)基纳米粒子得到了广泛的研究,因为它们作为造影剂具有很高的价值,可以提高 MRI(锰增强 MRI,MEMRI)中的信号强度和特异性。此外,Mn 可以作为活性氧(ROS)的清除剂,ROS 通常存在于神经退行性疾病的炎症过程中。本研究旨在开发纳米反应器,可作为 MEMRI 中的造影剂。将几种甲基丙烯酰化的凝胶多糖(GG-MA)和透明质酸(HA)混合物与不同类型的二氧化锰(MnO)纳米粒子混合,并进一步进行物理化学特性分析。进行了动态光散射、扫描电子显微镜、吸水和降解研究。还使用永生大鼠成纤维细胞系 L929 评估了不同配方的体外细胞毒性,培养时间长达 72 小时。合成的纳米粒子的平均粒径为 70nm,呈圆形形态。纳米粒子浓度或 HA 比例的变化不影响水凝胶的不同配方的稳定性。所合成的 MnO2(MnO2_S)纳米粒子的存在降低了水凝胶的细胞相容性,而商业上可获得的 1 型(MnO2_C1)纳米粒子对细胞的毒性较小。此外,当 HA 含量较低时,细胞增殖和活力增强。较高浓度(75 和 100ng/ml)的 MnO2_S 和 MnO2_C1 纳米粒子不会对细胞活力产生负面影响,而商业上可获得的 2 型(MnO2_C2)纳米粒子则产生相反的效果。需要进一步的研究来评估最有前途的纳米反应器配方在 MEMRI 联合应用和作为 ROS 清除剂的潜在应用。